financetom
Business
financetom
/
Business
/
Market Chatter: Google Request to Export Map Data Again Delayed by South Korea
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Google Request to Export Map Data Again Delayed by South Korea
Nov 11, 2025 3:09 AM

05:49 AM EST, 11/11/2025 (MT Newswires) -- Alphabet (GOOG, GOOGL) unit Google's ( GOOG ) request for permission to export map data was once again delayed by South Korea pending a request for additional documents, Reuters reported Tuesday, citing the country's land, infrastructure and transport ministry.

The ministry has given the technology giant until Feb. 5 to submit additional documents ahead of a decision by its National Geographic Information Institute, according to the report.

South Korea previously rejected such requests from Google ( GOOG ), Reuters reported.

The company didn't immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Southwest Airlines adds industry veteran Gangwal to board amid pressure from Elliott
Southwest Airlines adds industry veteran Gangwal to board amid pressure from Elliott
Jul 8, 2024
(Reuters) - Southwest Airlines ( LUV ) has appointed aviation industry veteran Rakesh Gangwal to its board of directors, it said on Monday, as increasing pressure from activist investor Elliott pushes the U.S. budget carrier to take defensive measures. Gangwal - who co-founded InterGlobe Aviation, the operator of India's largest airline IndiGo - has also served on the boards of...
NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment
NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment
Jul 8, 2024
08:45 AM EDT, 07/08/2024 (MT Newswires) -- NewAmsterdam Pharma ( NAMS ) said Monday it has completed patient enrollment for a phase 3 clinical trial evaluating the use of obicetrapib in combination with ezetimibe in adult patients with heterozygous familial hypercholesterolemia and/or either with or at risk of developing atherosclerotic cardiovascular disease. The 407 qualifying patients' low-density lipoproteins also are...
--Google No Longer Claims Carbon Neutrality in Environmental Report
--Google No Longer Claims Carbon Neutrality in Environmental Report
Jul 8, 2024
08:37 AM EDT, 07/08/2024 (MT Newswires) -- Price: 190.90, Change: -1.07, Percent Change: -0.55 ...
Aerovate Therapeutics to Explore Strategic Alternatives After Hypertension Trial Shutdown
Aerovate Therapeutics to Explore Strategic Alternatives After Hypertension Trial Shutdown
Jul 8, 2024
08:44 AM EDT, 07/08/2024 (MT Newswires) -- Aerovate Therapeutics ( AVTE ) said Monday it will consider strategic alternatives following its announcement that it was stopping enrollment and shutting down the phase 3 portion of its Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial and the long-term extension study. The company said it sought the assistance of Wedbush PacGrow in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved